(30) While this patient does not suffer from WD, Tempus testing suggests this patient has a germline mutation in ATP7B and could have been identified as high-risk before receiving platinum-based treatment, preventing his eventual MTT and Stage IV cancer diagnosis. The gene discussed is ATP7B; the disease is Wilson disease.